Cargando…
MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer
Approximately 30–50% of colorectal cancer (CRC) patients who undergo curative resection subsequently experience tumor recurrence or metastasis. Although microRNAs (miRNAs) are a class of small noncoding RNAs frequently deregulated in various human malignancies, it remains unknown if these can help p...
Autores principales: | Miyoshi, Jinsei, Toden, Shusuke, Yoshida, Kazuhiro, Toiyama, Yuji, Alberts, Steven R., Kusunoki, Masato, Sinicrope, Frank A., Goel, Ajay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338356/ https://www.ncbi.nlm.nih.gov/pubmed/28262692 http://dx.doi.org/10.1038/srep43393 |
Ejemplares similares
-
SNORA21 – An Oncogenic Small Nucleolar RNA, with a Prognostic Biomarker Potential in Human Colorectal Cancer
por: Yoshida, Kazuhiro, et al.
Publicado: (2017) -
TIAM1 promotes chemoresistance and tumor invasiveness in colorectal cancer
por: Izumi, Daisuke, et al.
Publicado: (2019) -
Oligomeric proanthocyanidins (OPCs) target cancer stem-like cells and suppress tumor organoid formation in colorectal cancer
por: Toden, Shusuke, et al.
Publicado: (2018) -
Changes in surgical therapies for rectal cancer over the past 100 years: A review
por: Toiyama, Yuji, et al.
Publicado: (2020) -
Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer
por: Toden, Shusuke, et al.
Publicado: (2016)